| Literature DB >> 31499188 |
Yingqian Chen1, Ji Cao1, Ning Zhang2, Bo Yang1, Qiaojun He1, Xuejing Shao3, Meidan Ying4.
Abstract
Differentiation therapy involves the use of agents that can induce differentiation in cancer cells, with the irreversible loss of tumour phenotype. The application of differentiation therapy in osteosarcoma has made progress because of a better understanding of the potential links between differentiation defects and tumorigenesis. Here, we review recent studies on differentiation therapy for osteosarcoma, describing a variety of differentiation inducers. By highlighting these examples of drug-induced osteosarcoma cell differentiation, we can acquire unique insights into not only osteosarcoma treatment, but also novel approaches to transform differentiating drugs into more effective therapies for other solid tumours.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31499188 DOI: 10.1016/j.drudis.2019.08.010
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851